Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Asthma

  Free Subscription


Articles published in Int Arch Allergy Immunol

Retrieve available abstracts of 85 articles:
HTML format



Single Articles


    January 2024
  1. SHU M, Xu H, Liang Y, Shi M, et al
    Long Non-Coding RNA BCYRN1 Drives Cellular Processes to Promote Asthma Development.
    Int Arch Allergy Immunol. 2024 Jan 15:1-12. doi: 10.1159/000535868.
    PubMed     Abstract available


  2. MATSUNO O
    Factors Affecting the Ability to Discontinue Oral Corticosteroid Use in Patients with EGPA Treated with Anti-Interleukin-5 Therapy.
    Int Arch Allergy Immunol. 2024;185:116-123.
    PubMed     Abstract available


    December 2023
  3. LIU L, Tian F, Sun Y, Li G, et al
    Exploring the Autoimmune Pathogenesis in Severe Asthma.
    Int Arch Allergy Immunol. 2023 Dec 7:1-7. doi: 10.1159/000535310.
    PubMed     Abstract available


    November 2023
  4. BRAVO-GUTIERREZ FJ, Miralles-Lopez JC, Valverde-Molina J, Alemany Frances ML, et al
    Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study.
    Int Arch Allergy Immunol. 2023 Nov 30:1-7. doi: 10.1159/000534902.
    PubMed     Abstract available


  5. CAKMAK ME, Oztop N, Yegit OO
    Comparison of the General Characteristics of Patients with Severe Asthma Who Switched from Omalizumab to Mepolizumab versus Patients Who Responded to Omalizumab Treatment: A Real-Life Study.
    Int Arch Allergy Immunol. 2023 Nov 22:1-9. doi: 10.1159/000534907.
    PubMed     Abstract available


  6. LIU HM, Rayner A, Mendelsohn AR, Shneyderman A, et al
    Applying Artificial Intelligence to Identify Common Targets for Treatment of Asthma, Eczema, and Food Allergy.
    Int Arch Allergy Immunol. 2023 Nov 21:1-12. doi: 10.1159/000534827.
    PubMed     Abstract available


    October 2023
  7. OGUZULGEN K, Ozturk AB, Bacceoglu A, Aydin O, et al
    Inhaler Steroid Use Changes Oral and Airway Bacterial and Fungal Microbiome Profile in Asthma Patients.
    Int Arch Allergy Immunol. 2023 Oct 16:1-10. doi: 10.1159/000531866.
    PubMed     Abstract available


    September 2023
  8. CHIANG TY, Lee HY, Chien WC, Su HC, et al
    The Relationship between Allergic Disease and Sexual Dysfunction: A Scoping Review.
    Int Arch Allergy Immunol. 2023 Sep 20:1-13. doi: 10.1159/000533403.
    PubMed     Abstract available


  9. TONG N, Liu D, Lu L, Lin R, et al
    miR-410 Regulates Helper T Cell Differentiation in Ovalbumin-Induced Asthma through the PI3K-AKT-VEGF Signaling Pathway.
    Int Arch Allergy Immunol. 2023 Sep 19:1-9. doi: 10.1159/000531493.
    PubMed     Abstract available


  10. LI Y, Zou C, Li J, Wang W, et al
    Airway Microbiome Composition and Co-Occurrence Network Are Associated with Inflammatory Phenotypes of Asthma.
    Int Arch Allergy Immunol. 2023 Sep 8:1-10. doi: 10.1159/000533315.
    PubMed     Abstract available


  11. WANG H, Wang J, Song Z, Guo J, et al
    Risk Factors for Acute Rhinosinusitis in Childhood Asthma.
    Int Arch Allergy Immunol. 2023 Sep 5:1-5. doi: 10.1159/000533329.
    PubMed     Abstract available


    August 2023
  12. SATO E, Seo Y, Tagaya E, Yagi O, et al
    Higher Prevalence and Severity of Eosinophilic Otitis Media in Patients with Asthma-COPD Overlap Compared with Asthma Alone.
    Int Arch Allergy Immunol. 2023 Aug 24:1-10. doi: 10.1159/000531980.
    PubMed     Abstract available


  13. SHIMIZU M, Kato T, Adachi Y, Wada T, et al
    Maternal Dietary Vitamin D Intake during Pregnancy Is Associated with Allergic Disease Symptoms in Children at 3 Years Old: The Japan Environment and Children's Study.
    Int Arch Allergy Immunol. 2023 Aug 22:1-10. doi: 10.1159/000531970.
    PubMed     Abstract available


  14. GUO J, Wang J, Xu X, Yang Y, et al
    Risk Factors for Abnormal Small Airway Function Indicators in Nasal Polyp Patients with and without Asthma.
    Int Arch Allergy Immunol. 2023 Aug 18:1-7. doi: 10.1159/000532068.
    PubMed     Abstract available


  15. CAO J, Liu M, Wang Z, Huang Y, et al
    Interaction between Serum Cotinine and Magnesium Intake with Childhood Asthma: A Cross-Sectional Study.
    Int Arch Allergy Immunol. 2023 Aug 18:1-9. doi: 10.1159/000531730.
    PubMed     Abstract available


  16. XU C, Du L, Guo Y, Liang Y, et al
    TCN1 Expression Is Increased in Asthma.
    Int Arch Allergy Immunol. 2023 Aug 16:1-8. doi: 10.1159/000531073.
    PubMed     Abstract available


  17. STRUSS N, Dieter S, Schwarz K, Badorrek P, et al
    Sodium Chloride versus Lactose as a Carrier for House Dust Mite Allergen in Allergen Chamber Studies: A Clinical Study to Assess Noninferiority.
    Int Arch Allergy Immunol. 2023 Aug 16:1-10. doi: 10.1159/000531878.
    PubMed     Abstract available


    July 2023
  18. YILDIZ E, Colkesen F, Arslan S, Evcen R, et al
    Allergic Diseases as a Clinical Phenotype Marker in Patients with Common Variable Immunodeficiency.
    Int Arch Allergy Immunol. 2023 Jul 20:1-9. doi: 10.1159/000530901.
    PubMed     Abstract available


  19. GAO Y, Li J, Xu X, Wang C, et al
    Sensitisation to House Dust Mite Component Der p 23 Is Associated with Severe Symptoms and Asthma in Allergic Rhinitis Patients.
    Int Arch Allergy Immunol. 2023 Jul 12:1-8. doi: 10.1159/000531244.
    PubMed     Abstract available


    June 2023
  20. SIO YY, Gan WL, Ng WS, Matta SA, et al
    The ERBB2 Exonic Variant Pro1170Ala Modulates Mitogen-Activated Protein Kinase Signaling Cascades and Associates with Allergic Asthma.
    Int Arch Allergy Immunol. 2023 Jun 19:1-12. doi: 10.1159/000530960.
    PubMed     Abstract available


  21. GU Z, Wei P, Kou W, Tang XY, et al
    Analysis of Multimorbidity of Moderate to Severe Allergic Rhinitis in Children: A Real-World Study.
    Int Arch Allergy Immunol. 2023 Jun 8:1-11. doi: 10.1159/000530842.
    PubMed     Abstract available


    May 2023
  22. SAKAI N, Koya T, Murai Y, Tsubokawa F, et al
    Effect of Benralizumab on Mucus Plugs in Severe Eosinophilic Asthma.
    Int Arch Allergy Immunol. 2023 May 16:1-9. doi: 10.1159/000530392.
    PubMed     Abstract available


  23. SIO YY, Shi P, Matta SA, Fok YTR, et al
    Functional Polymorphisms of the Arachidonic Acid Pathway Associate with Risks and Clinical Outcomes of Allergic Diseases.
    Int Arch Allergy Immunol. 2023;184:609-623.
    PubMed     Abstract available


    March 2023
  24. OHBAYASHI H, Hozawa S, Bertran A, Yoshisue H, et al
    Prevalence of Uncontrolled Asthma despite Treatment with Medium- or High-Dose ICS/LABA Using Patient-Reported Outcomes in Japan: The KOCU (KnOwing the Controlled statUs of Asthma in Japan) Study.
    Int Arch Allergy Immunol. 2023 Mar 30:1-12. doi: 10.1159/000529251.
    PubMed     Abstract available


  25. CAKMAK ME, Oztop N, Yegit OO, Ozdedeoglu O, et al
    Evaluation of the Clinical Features and Laboratory Data of Patients with Severe Eosinophilic Asthma Classified as Super-Responders, Partial Responders, or Nonresponders to Mepolizumab Treatment: A Real-Life Study.
    Int Arch Allergy Immunol. 2023 Mar 30:1-8. doi: 10.1159/000529760.
    PubMed     Abstract available


  26. YUKSEL ASLIER NG, Saatci O, Aslier M
    Disease and Quality of Life Aspects of Cat Allergy in Non-Pet Owners with Allergic Rhinitis.
    Int Arch Allergy Immunol. 2023 Mar 29:1-9. doi: 10.1159/000529275.
    PubMed     Abstract available


    February 2023
  27. WANG D, Ito C, Homma Y, Arimitsu M, et al
    Prevalence and Clinical Characteristics of Patients with Moderate-to-Severe Asthma in Japan Using a JMDC Claims Database.
    Int Arch Allergy Immunol. 2023 Feb 16:1-9. doi: 10.1159/000528987.
    PubMed     Abstract available


    January 2023
  28. XU C, Du L, Guo Y, Liang Y, et al
    Differential Circular RNA Expression Profiles in Induced Sputum of Patients with Asthma.
    Int Arch Allergy Immunol. 2023 Jan 23:1-11. doi: 10.1159/000528129.
    PubMed     Abstract available


  29. ROGER A, Lazo C, Arias N, Quirant B, et al
    Using Component-Resolved Diagnosis to Characterize the Sensitization to Specific Cat and Dog Allergens in Patients with Allergic Respiratory Diseases in Catalonia, Spain.
    Int Arch Allergy Immunol. 2023 Jan 19:1-7. doi: 10.1159/000528643.
    PubMed     Abstract available


  30. FENG H, Xiong X, Chen Z, Xu Q, et al
    Prevalence and Influencing Factors of Food Allergy in Global Context: A Meta-Analysis.
    Int Arch Allergy Immunol. 2023 Jan 12:1-33. doi: 10.1159/000527870.
    PubMed     Abstract available


  31. ZHANG Z, Li G, Yu L, Jiang J, et al
    Using a Two-Sample Mendelian Randomization Study Based on Genome-Wide Association Studies to Assess and Demonstrate the Causal Effects of Allergic Rhinitis on Chronic Lower Respiratory Diseases and Lung Function.
    Int Arch Allergy Immunol. 2023 Jan 11:1-9. doi: 10.1159/000528350.
    PubMed     Abstract available


  32. BU ML, Li MH, Feng M, Wang JR, et al
    Poly(I:C) Exacerbates Airway Goblet Cell Hyperplasia and Lung Inflammation in HDM-Exposed Balb/C Mice by YAP/FOXM1 Pathway.
    Int Arch Allergy Immunol. 2023;184:707-719.
    PubMed     Abstract available


  33. SATO S, Kawano T, Ike E, Takahashi K, et al
    IL-1beta Derived Th17 Immune Responses Are a Critical Factor for Neutrophilic-Eosinophilic Airway Inflammation on Psychological Stress-Induced Immune Tolerance Breakdown in Mice.
    Int Arch Allergy Immunol. 2023;184:797-807.
    PubMed     Abstract available


    December 2022
  34. PATCHETT BJ, Nriagu BN, Mavraj G, Patel RR, et al
    Allergic Polysensitization Clusters: Newly Recognized Severity Marker in Urban Asthmatic Adults.
    Int Arch Allergy Immunol. 2022 Dec 21:1-12. doi: 10.1159/000526706.
    PubMed     Abstract available


  35. ABBASI-DOKHT T, Sadrifar S, Forouzandeh S, Malek F, et al
    Multistrain Probiotics Supplement Alleviates Asthma Symptoms via Increasing Treg Cells Population: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Int Arch Allergy Immunol. 2022 Dec 9:1-11. doi: 10.1159/000526739.
    PubMed     Abstract available


  36. TSUBOKAWA F, Koya T, Murai Y, Tanaka K, et al
    Effects of Benralizumab on Three-Dimensional Computed Tomography Analysis in Severe Eosinophilic Asthma.
    Int Arch Allergy Immunol. 2022 Dec 5:1-9. doi: 10.1159/000525846.
    PubMed     Abstract available


  37. AKARSU A, Oksel Karakus C, Ocak M, Oral N, et al
    Exploring the Heterogeneity of IgE-Mediated Food Allergy through Latent Class Analysis.
    Int Arch Allergy Immunol. 2022 Dec 5:1-8. doi: 10.1159/000527534.
    PubMed     Abstract available


  38. HOTTA M, Ueda K, Ikehara S, Tanigawa K, et al
    The Duration of Neonatal Phototherapy and Allergic Disorders: The Japan Environment and Children's Study.
    Int Arch Allergy Immunol. 2022 Dec 5:1-9. doi: 10.1159/000527381.
    PubMed     Abstract available


    November 2022
  39. LYLY A, Genberg E, Kauppi P, Virkkula P, et al
    Real-Life Experience of Biologic Treatment for Asthma on Chronic Rhinosinusitis: A Finnish Cohort.
    Int Arch Allergy Immunol. 2022 Nov 7:1-12. doi: 10.1159/000526365.
    PubMed     Abstract available


  40. YAVUZ ST, Koc O, Kaya G, Gulec M, et al
    Risk Factors for Exacerbations in School-Age Children with Asthma.
    Int Arch Allergy Immunol. 2022 Nov 3:1-7. doi: 10.1159/000527220.
    PubMed     Abstract available


    October 2022
  41. SUN Y, Xia T, Ma J, Sun Y, et al
    IL-12 Contributes to the Development of Asthma by Targeting HIF-1alpha/NLRP3 Pathway through Runx3.
    Int Arch Allergy Immunol. 2022 Oct 12:1-10. doi: 10.1159/000526803.
    PubMed     Abstract available


  42. KIM MH, Sohn KH, Park HJ, Nam YH, et al
    Multicenter Prospective Observational Study to Evaluate the Therapeutic Effect and Safety of a Combination of Montelukast and Levocetirizine for Allergic Rhinitis when Administered to Patients with Allergic Rhinitis and Asthma.
    Int Arch Allergy Immunol. 2022 Oct 7:1-8. doi: 10.1159/000526094.
    PubMed     Abstract available


  43. KAMA Y, Yamada Y, Koike T, Enseki M, et al
    Allergic Sensitization Is Crucial for the Suppressive Role of Streptococcus pneumoniae in the Acute Exacerbation of Asthma.
    Int Arch Allergy Immunol. 2022 Oct 6:1-11. doi: 10.1159/000526408.
    PubMed     Abstract available


    September 2022
  44. GIULIANO AFM, Buquicchio R, Patella V, Bedbrook A, et al
    Rediscovering Allergic Rhinitis: The Use of a Novel mHealth Solution to Describe and Monitor Health-Related Quality of Life in Elderly Patients.
    Int Arch Allergy Immunol. 2022 Sep 6:1-11. doi: 10.1159/000525595.
    PubMed     Abstract available


  45. DU L, Xu C, Shi J, Tang L, et al
    Elevated CXCL14 in Induced Sputum Was Associated with Eosinophilic Inflammation and Airway Obstruction in Patients with Asthma.
    Int Arch Allergy Immunol. 2022 Sep 5:1-10. doi: 10.1159/000526367.
    PubMed     Abstract available


    August 2022
  46. ARSLAN B, Pacaci Cetin G, Turk M, Gulmez I, et al
    Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?
    Int Arch Allergy Immunol. 2022 Aug 2:1-7. doi: 10.1159/000525723.
    PubMed     Abstract available


    June 2022
  47. YANG Y, Huang G, Xu Q, Zhao G, et al
    miR-146a-5p Attenuates Allergic Airway Inflammation by Inhibiting the NLRP3 Inflammasome Activation in Macrophages.
    Int Arch Allergy Immunol. 2022 Jun 3:1-12. doi: 10.1159/000524718.
    PubMed     Abstract available


    May 2022
  48. KOJIMA R, Shinohara R, Kushima M, Horiuchi S, et al
    Prenatal Negative Life Events and Childhood Allergies: The Japan Environment and Children's Study (JECS).
    Int Arch Allergy Immunol. 2022 May 19:1-9. doi: 10.1159/000524854.
    PubMed     Abstract available


  49. ZONG W, Liang Y, Mo Y
    Increased SERPINB10 Expression in Induced Sputum Was Associated with Airway Type 2 Inflammation in Asthma.
    Int Arch Allergy Immunol. 2022 May 6:1-7. doi: 10.1159/000524613.
    PubMed     Abstract available


    April 2022
  50. CHEN L, Wang W, Leng Q, Cong L, et al
    Associations of the Methylation Levels of NFAT5, PVT1, RPS6KA1, and MIB1 with Steroid-Resistant Asthma.
    Int Arch Allergy Immunol. 2022 Apr 13:1-12. doi: 10.1159/000524080.
    PubMed     Abstract available


    March 2022
  51. HUANG QP, Xie ZF, Huang J
    Assessment of the Association between Genetic Polymorphisms in the CHI3L1 Gene and Asthma Risk.
    Int Arch Allergy Immunol. 2022 Mar 25:1-12. doi: 10.1159/000522393.
    PubMed     Abstract available


    February 2022
  52. ZONG W, Mo Y, Liang Y
    Correlation between Increased Monocyte Chemotactic Protein 1 Level and Lung Function in Patients with Asthma.
    Int Arch Allergy Immunol. 2022 Feb 23:1-9. doi: 10.1159/000521946.
    PubMed     Abstract available


  53. SCHIFFER M, Peters K, Peters M
    Comparison of Airway Remodeling in Two Different Endotypes of Allergic Asthma.
    Int Arch Allergy Immunol. 2022 Feb 22:1-12. doi: 10.1159/000522189.
    PubMed     Abstract available


  54. XU C, Du L, Zeng Z, Chen F, et al
    Elevated CEACAM5 Levels in Patients with Asthma.
    Int Arch Allergy Immunol. 2022 Feb 16:1-9. doi: 10.1159/000521754.
    PubMed     Abstract available


  55. FENG Y, Zhang S, Shang Y, Chen N, et al
    The Use of Exercise Challenge Testing and Fractional Exhaled Nitric Oxide in Diagnosis of Chest Tightness Variant Asthma in Children.
    Int Arch Allergy Immunol. 2022 Feb 14:1-8. doi: 10.1159/000522062.
    PubMed     Abstract available


  56. RYDELL N, Nagao M, Moverare R, Ekoff H, et al
    Serum Eosinophilic Cationic Protein Is a Reliable Biomarker for Childhood Asthma.
    Int Arch Allergy Immunol. 2022 Feb 10:1-9. doi: 10.1159/000521890.
    PubMed     Abstract available


    January 2022
  57. TAKEUCHI H, Takanashi S, Hasan SMT, Hore SK, et al
    Anti-Ascaris IgE as a Risk Factor for Asthma Symptoms among 5-Year-Old Children in Rural Bangladesh with Even Decreased Ascaris Infection Prevalence.
    Int Arch Allergy Immunol. 2022 Jan 31:1-11. doi: 10.1159/000521717.
    PubMed     Abstract available


  58. KAMA Y, Yamada Y, Koike T, Suzuki K, et al
    Antibiotic Treatments Prolong the Wheezing Period in Acute Exacerbation of Childhood Bronchial Asthma.
    Int Arch Allergy Immunol. 2022 Jan 24:1-11. doi: 10.1159/000521192.
    PubMed     Abstract available


  59. FILIOU A, Holmdahl I, Asarnoj A, van Hage M, et al
    Development of Sensitization to Multiple Allergen Molecules from Preschool to School Age Is Related to Asthma.
    Int Arch Allergy Immunol. 2022 Jan 18:1-12. doi: 10.1159/000521324.
    PubMed     Abstract available


  60. FUKUMITSU K, Nishiyama H, Kanemitsu Y, Takeda N, et al
    Pretreatment Alveolar Nitric Oxide Levels Predict Improvement of Pulmonary Function 1 Year Following Anti-Asthma Treatments in Patients with Inhaled Corticosteroid-Naive Asthma.
    Int Arch Allergy Immunol. 2022 Jan 14:1-11. doi: 10.1159/000520508.
    PubMed     Abstract available


  61. SOTO A, Perrone Sibilia M, Sanchez VR, Arcon N, et al
    Contribution of Kazal-Like Domains of the Serine Protease Inhibitor-1 from Toxoplasma gondii in Asthma Therapeutic Vaccination Effectiveness.
    Int Arch Allergy Immunol. 2022 Jan 11:1-8. doi: 10.1159/000520796.
    PubMed     Abstract available


  62. MING X, Yu X, Li J, Wang J, et al
    Salidroside Attenuates Airway Inflammation and Remodeling via the miR-323-3p/SOCS5 Axis in Asthmatic Mice.
    Int Arch Allergy Immunol. 2022;183:424-434.
    PubMed     Abstract available


  63. WANG Z, Zhang J, Yan H, Dong L, et al
    Kawasaki Disease and Atopic Diseases: A Systematic Review and Meta-Analysis of Observational Studies.
    Int Arch Allergy Immunol. 2022;183:389-397.
    PubMed     Abstract available


  64. YOOMA P, Manuyakorn W, Sawatchai A, Jotikasthira W, et al
    Serum Periostin Predicts Wheezing Exacerbation: A Prospective Study in Preschool Children with Recurrent Wheezing.
    Int Arch Allergy Immunol. 2022;183:271-278.
    PubMed     Abstract available


  65. LIU Y, Zhang M, Zhang H, Qian X, et al
    Anthocyanins Inhibit Airway Inflammation by Downregulating the NF-kappaB Pathway via the miR-138-5p/SIRT1 Axis in Asthmatic Mice.
    Int Arch Allergy Immunol. 2022;183:539-551.
    PubMed     Abstract available


  66. LUAN X, Cui C, Jiang J, Wang C, et al
    Salidroside Mitigates Airway Inflammation in Asthmatic Mice via the AMPK/Akt/GSK3beta Signaling Pathway.
    Int Arch Allergy Immunol. 2022;183:326-336.
    PubMed     Abstract available


  67. ZHANG Y, Yan L, Yang J, Li X, et al
    Silencing of FSTL1 Alleviated LPS-Induced Inflammatory Damage and Oxidative Damage in Human Bronchial Epithelial Cells via BMP4/KLF4 Axis.
    Int Arch Allergy Immunol. 2022;183:785-795.
    PubMed     Abstract available


  68. PUXEDDU I, Petrelli F, Cristofani-Mencacci L, Scarano M, et al
    Component-Resolved Diagnosis for Endotyping Patients with Chronic Rhinosinusitis with Nasal Polyps.
    Int Arch Allergy Immunol. 2022;183:770-777.
    PubMed     Abstract available


  69. LOPEZ-RODRIGUEZ R, Rial MJ, Esteban-Gorgojo I, Veleiro Perez B, et al
    Serodominance Profile in a Dust Mite Complex Region.
    Int Arch Allergy Immunol. 2022;183:843-851.
    PubMed     Abstract available


  70. HAN J, Wang W, Zhu Z, Wang L, et al
    Profile of Tissue Immunoglobulin E in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps.
    Int Arch Allergy Immunol. 2022;183:835-842.
    PubMed     Abstract available


  71. LI J, Wang X, Su Y, Hu S, et al
    TRIM33 Modulates Inflammation and Airway Remodeling of PDGF-BB-Induced Airway Smooth-Muscle Cells by the Wnt/beta-Catenin Pathway.
    Int Arch Allergy Immunol. 2022;183:1127-1136.
    PubMed     Abstract available


  72. OZDEL OZTURK B, Yavuz Z, Aydin O, Mungan D, et al
    Effectiveness of Low-Dose Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Real-Life Experience.
    Int Arch Allergy Immunol. 2022;183:1281-1290.
    PubMed     Abstract available


    December 2021
  73. GOKMIRZA OZDEMIR P, Celik V
    Current Recommendations on the Management of Pediatric Asthma and Allergic Rhinitis during the COVID-19 Pandemic versus Real-Life Practice.
    Int Arch Allergy Immunol. 2021 Dec 28:1-8. doi: 10.1159/000521117.
    PubMed     Abstract available


  74. HE R, Chen Y, Chen X, Yuan B, et al
    Mechanism of miR-181a-5p in Regulatory T/T-Helper 17 Immune Imbalance and Asthma Development in Mice with Allergic Rhinitis.
    Int Arch Allergy Immunol. 2021 Dec 23:1-14. doi: 10.1159/000519703.
    PubMed     Abstract available


  75. OZDEL OZTURK B, Yavuz Z, Eraslan D, Mungan D, et al
    Mepolizumab Is an Effective Option in Severe Eosinophilic Asthma Regardless of Baseline Features: Single-Center Real-Life Data.
    Int Arch Allergy Immunol. 2021 Dec 14:1-13. doi: 10.1159/000520725.
    PubMed     Abstract available


  76. REINSBERG M, Siebert S, Dreher C, Bogs T, et al
    Predictors of Airway Hyperresponsiveness in Symptomatic Children with Normal Spirometry and Suspicious of Possible Asthma.
    Int Arch Allergy Immunol. 2021 Dec 10:1-9. doi: 10.1159/000520670.
    PubMed     Abstract available


    October 2021
  77. TORRE E, Sola D, Caramaschi A, Mignone F, et al
    A Pilot Study on Clinical Scores, Immune Cell Modulation, and Microbiota Composition in Allergic Patients with Rhinitis and Asthma Treated with a Probiotic Preparation.
    Int Arch Allergy Immunol. 2021 Oct 21:1-15. doi: 10.1159/000518952.
    PubMed     Abstract available


  78. ALABED M, Sultana Shaik A, Saheb Sharif-Askari N, Saheb Sharif-Askari F, et al
    Enhanced Infiltration of Central Memory T Cells to the Lung Tissue during Allergic Lung Inflammation.
    Int Arch Allergy Immunol. 2021 Oct 20:1-15. doi: 10.1159/000518835.
    PubMed     Abstract available


  79. KOYA T, Sakai N, Sasaki T, Shinbori K, et al
    Effect of Dupilumab on Depression in Asthma with Eosinophilic Chronic Rhinosinusitis in the Japanese Population.
    Int Arch Allergy Immunol. 2021 Oct 15:1-9. doi: 10.1159/000519296.
    PubMed     Abstract available


  80. PAN HH, Ko JL, Wu CT, Sun HL, et al
    Effect of the Fungal Immunomodulatory Protein FIP-fve in the Neutrophilic Asthma Animal Model.
    Int Arch Allergy Immunol. 2021 Oct 14:1-12. doi: 10.1159/000517184.
    PubMed     Abstract available


    September 2021
  81. INOUE H, Akimoto K, Ikeda H, Sato H, et al
    Comprehensive Gene Expression Signature Using RNA-Seq in Airways of Mouse Model of Severe Asthma with Fungal Sensitization.
    Int Arch Allergy Immunol. 2021 Sep 29:1-11. doi: 10.1159/000519172.
    PubMed     Abstract available


  82. VENTURA MT, Giuliano AFM, Buquicchio R, Bedbrook A, et al
    Implementation of the MASK-Air(R) App for Rhinitis and Asthma in Older Adults: MASK@Puglia Pilot Study.
    Int Arch Allergy Immunol. 2021 Sep 22:1-6. doi: 10.1159/000518032.
    PubMed     Abstract available


  83. SAHINER UM, Arik Yilmaz E, Fontanella S, Haider S, et al
    The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?
    Int Arch Allergy Immunol. 2021 Sep 9:1-10. doi: 10.1159/000517865.
    PubMed     Abstract available


    January 2021
  84. METBULUT AP, Mustafaoglu O, Sen G, Kanik Yuksek S, et al
    Evaluation of the Clinical and Laboratory Findings of Asthmatic Children with SARS-CoV-2 Infection.
    Int Arch Allergy Immunol. 2021;182:989-996.
    PubMed     Abstract available


  85. HE Y, Liu J, Zhao D, Zhang S, et al
    The IgE Blocking Activity Induced by Dermatophagoides pteronyssinus Subcutaneous Immunotherapy Does Not Correlate with Specific IgA but with IgG4 in both Serum and Saliva.
    Int Arch Allergy Immunol. 2021;182:1231-1244.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.